For APS-1 patients, it has been shown that Abs against omega-interferon (IFN-ω) are 100% specific and antibodies against alpha2-interferon (IFN-α2) are 99.9% specific [3]. This evidence concerns the gene IFNA2 and autoimmune polyendocrine syndrome type 1.